Zevra Therapeutics, Inc. ZVRA Business Segments — Revenue, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s business segments — revenue, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s business segments — revenue, net?
- Zevra Therapeutics, Inc. (ZVRA) reported business segments — revenue, net of $36.22M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s business segments — revenue, net changed year-over-year?
- Zevra Therapeutics, Inc.'s business segments — revenue, net increased by 77.5% year-over-year, from $20.4M to $36.22M.
- What does business segments — revenue, net mean?
- Represents the total net revenue generated by the company's primary business segment after accounting for returns, allowances, and discounts. This metric serves as a key indicator of the segment's market adoption and commercial success in delivering rare disease therapies.